RS Research
RS Research is a biotechnology company that develops targeted oncology therapies using its proprietary Sagitta drug-delivery platform. The company creates polymer-drug conjugates designed to improve the therapeutic index of chemotherapy by reducing toxicity while maintaining efficacy. Their lead investigational candidate, RS-0139, has successfully completed Phase 1 clinical trials for patients with solid tumors.
Visit websiteIstanbul, Türkiye
Biotechnology
Oncology
Pharmaceuticals
Healthtech
Funding summary
- Total raised
- €11.8M
- Funding rounds
- 2
Investors in RS Research
Investors on record for RS Research. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like RS Research?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors